ECIA (Encision) Common Stock : $24.41 Mil (As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Encision Common Stock?

Encision's quarterly common stock increased from Jun. 2024 ($24.38 Mil) to Sep. 2024 ($24.40 Mil) and increased from Sep. 2024 ($24.40 Mil) to Dec. 2024 ($24.41 Mil).

Encision's annual common stock increased from Mar. 2022 ($24.28 Mil) to Mar. 2023 ($24.35 Mil) and increased from Mar. 2023 ($24.35 Mil) to Mar. 2024 ($24.37 Mil).

Encision Common Stock Historical Data

The historical data trend for Encision's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encision Common Stock Chart

Encision Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Common Stock

Get a 7-Day Free Trial

24.23

24.27

24.28

24.35

24.37

Encision Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															24.40	24.37	24.38	24.40	24.41

Encision Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Encision Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Encision Inc (OTCPK:ECIA) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

6797 Winchester Circle, Boulder, CO, USA, 80301

Website

https://www.encision.com

Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provide surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities. Maximum revenue is generated from the product segment.

Executives

Robert H Fries	director	800 FILLMORE ST, DENVER CO 80206
Gregory J. Trudel	director, officer: CEO	5241 RIMROCK LANE, FORT COLLINS CO 80526
Peter D Geary	officer: VP of Operations	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Jason E Johnson	officer: VP Sales	17752 WEDGEWOOD LANE, PRIOR LAKE MN 55372
Patrick R Dixon	director	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brian J Jackman	director	6797 WINCHESTER CIRCLE, SUITE 100, BOULDER CO 80301
Von Der Lippe Paul	director	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Denise Baker	director	6797 WINCHESTER CIRCLE, BOULDER X1 80301
Vern D Kornelsen	director, 10 percent owner	4605 S. DENICE DR, ENGLEWOOD CO 80111
Partners Lllp Cmed	10 percent owner
Patrick W Pace	director	3701 SOARING EAGLE, AUSTIN TX 78746
Michael Biggs	officer: VP Engineering	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brad Greathouse	officer: VP RA/QA	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Valerie Ray	officer: VP of Operations	6797 WINCHESTER CIRCLE, BOULDER CO 80301
David W Newton	director, officer: VP Technology	8099 NORTH 63RD STREET, LONGMONT CO 80503